Hereditary cancer
Information
- Disease name
- Hereditary cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03934606 | Active, not recruiting | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | January 1, 2018 | December 31, 2024 | |
| NCT04242667 | Completed | N/A | Penn Biobank Return of Research Results Program | March 1, 2020 | August 1, 2023 |
| NCT05805982 | Completed | N/A | Educational Video Versus In-person Genetic Counseling for Hereditary Cancer | August 10, 2020 | January 3, 2023 |
| NCT03067389 | Completed | Combined Breast Cancer Risk Study | February 6, 2016 | January 8, 2019 | |
| NCT03982446 | Completed | Germline Mutations in Pancreatic Adenocarcinoma | March 1, 2016 | January 3, 2020 | |
| NCT03081455 | Completed | Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes | February 13, 2017 | August 4, 2017 | |
| NCT03421327 | Completed | Genetic Risk: Whether, When, and How to Tell Adolescents | September 1, 2017 | December 31, 2018 | |
| NCT06378749 | Recruiting | N/A | Previvors Recharge: A Resilience Program for Cancer Previvors | April 11, 2024 | July 31, 2024 |
| NCT04104230 | Recruiting | Quebec Pancreas Cancer Study | March 12, 2012 | January 2025 | |
| NCT04214210 | Recruiting | N/A | The DIALOGUE Study: Swiss-Korean Billateral Collaboration | April 15, 2022 | December 31, 2024 |
| NCT06073626 | Recruiting | N/A | Personalized Oncology Promoting Equity for Black Lives | February 16, 2024 | August 31, 2027 |
| NCT06157801 | Recruiting | Evaluation of Hereditary Cancer Educational Videos | April 5, 2024 | October 31, 2024 | |
| NCT06284330 | Recruiting | N/A | CHARGE Study: CHoice ARchitecture Genetic tEsting | February 16, 2024 | August 2025 |
| NCT03319290 | Unknown status | Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies | October 17, 2017 | October 17, 2020 |